We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.61%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$6.5B
AUM Growth
+$106M
(+1.7%)
Cap. Flow
-$484M
Cap. Flow
% of AUM
-7.44%
Top 10 Holdings %
Top 10 Hldgs %
52.66%
Holding
925
New
127
Increased
448
Reduced
289
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$56.2M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$44.4M |
| 3 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$24.2M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$24.1M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$94.9M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$83.7M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$82.4M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$79.7M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$67.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.12% |
| 2 | Technology | 8.06% |
| 3 | Healthcare | 5.67% |
| 4 | Energy | 5.37% |
| 5 | Real Estate | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Weyerhaeuser
WY
$17.7B
| $4.33M | 0.07% |
143,248
+11,644
| +9% | +$338K |
|
152
Monolithic Power Systems
MPWR
$63B
| $4.3M | 0.07% |
24,165
+3,359
| +16% | +$536K |
|
153
Intuitive Surgical
ISRG
$130B
| $4.27M | 0.07% |
21,657
+9,027
| +71% | +$1.69M |
|
|
EXAS
154
DELISTED
Exact Sciences
EXAS
| $4.18M | 0.06% |
45,224
-15,759
| -26% | -$1.39M |
|
155
Abbott
ABT
$187B
| $4.15M | 0.06% |
47,727
+44,527
| +1,391% | +$3.73M |
|
156
AGNC Investment
AGNC
$12.9B
| $4.14M | 0.06% |
233,946
+151,239
| +183% | +$2.57M |
|
157
Ventas
VTR
$47.7B
| $4.13M | 0.06% |
71,622
+6,202
| +9% | +$389K |
|
158
Medtronic
MDT
$111B
| $4.11M | 0.06% |
36,197
+19,570
| +118% | +$2.15M |
|
159
Boston Properties
BXP
$11.2B
| $4.1M | 0.06% |
29,734
+2,419
| +9% | +$326K |
|
|
ICPT
160
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.07M | 0.06% |
32,865
-61,232
| -65% | -$5.48M |
|
|
GBT
161
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.06M | 0.06% |
51,029
-68,944
| -57% | -$4.09M |
|
162
M&T Bank
MTB
$36.6B
| $4.04M | 0.06% |
23,832
+1,483
| +7% | +$241K |
|
163
Corpay
CPAY
$25.1B
| $4.02M | 0.06% |
13,987
+1,104
| +9% | +$326K |
|
164
HF Sinclair
DINO
$16.1B
| $4M | 0.06% |
78,941
-68,163
| -46% | -$3.61M |
|
165
iShares MSCI Japan ETF
EWJ
$21.3B
| $3.98M | 0.06% |
67,142
+30,000
| +81% | +$1.77M |
|
|
MDCO
166
DELISTED
Medicines Co
MDCO
| $3.96M | 0.06% |
46,584
-89,146
| -66% | -$5.94M |
|
|
FITB
167
Fifth Third Bancorp
FITB
$52.4B
| $3.96M | 0.06% |
128,659
+5,502
| +4% | +$161K |
|
168
CBRE Group
CBRE
$43.1B
| $3.92M | 0.06% |
63,919
+5,196
| +9% | +$288K |
|
|
SAGE
169
DELISTED
Sage Therapeutics
SAGE
| $3.89M | 0.06% |
53,837
+13,276
| +33% | +$1.63M |
|
170
Exelixis
EXEL
$14.2B
| $3.88M | 0.06% |
220,154
-116,767
| -35% | -$1.98M |
|
171
Ligand Pharmaceuticals
LGND
$5.94B
| $3.86M | 0.06% |
59,309
-47,335
| -44% | -$3.16M |
|
172
Alnylam Pharmaceuticals
ALNY
$38.5B
| $3.86M | 0.06% |
33,497
-44,138
| -57% | -$4.4M |
|
173
United Therapeutics
UTHR
$26.1B
| $3.85M | 0.06% |
43,769
-36,553
| -46% | -$3.22M |
|
174
Sarepta Therapeutics
SRPT
$1.63B
| $3.85M | 0.06% |
29,828
-45,686
| -61% | -$4.61M |
|
|
BLUE
175
DELISTED
bluebird bio
BLUE
| $3.84M | 0.06% |
3,375
-1,399
| -29% | -$1.52M |
|
Similar funds
CS
AF
SC
JG
SO
Rafferty Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Rafferty Asset Management held 925 positions worth $6.5B, up 1.7% from $6.39B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Rafferty Asset Management withdrew a net $484M in Q4 2019, closing 61 positions and reducing 289 holdings. Its most notable exit was State Street Health Care Select Sector SPDR ETF, an estimated $83.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Rafferty Asset Management opened a new position in Moderna worth $3.18M.
- Rafferty Asset Management's largest Q4 2019 buy was Moderna: 162,744 shares worth $3.18M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $56.2M increase.
- Rafferty Asset Management's biggest Q4 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.9M.
- Rafferty Asset Management fully exited State Street Health Care Select Sector SPDR ETF in Q4 2019, selling an estimated $83.7M.
- Rafferty Asset Management's ten largest holdings make up 53% of its $6.5B portfolio in Q4 2019.
- Rafferty Asset Management opened 127 new positions and closed 61 in Q4 2019.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $6.5B.
Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.